Table 1.

Baseline demographics and characteristics of 29 eyes in 29 patients with central serous chorioretinopathy.

Patients’ Characteristics	Values
Patients (eyes), n	29 (29)
Age (years), mean ± SD	50.5 ± 9.8
Sex, n (%)	Male 24 (82.8%), Female 5 (17.2%)
Duration of current episode (months), mean ± SD	34.21 ± 38.91
Number of episodes (n), mean ± SD	3.64 ± 3.38
Number of patients who underwent previous intravitreal bavacizumab injection, n (%)	19 (65.5%)
BCVA (logMAR), mean ± SD	0.34 ± 0.31
CFT (μm), mean ± SD	309.31 ± 81.6
SRF height (μm), mean ± SD	138.36 ± 56.78
MD (dB) of microperimetry, mean ± SD	−1.56 ± 1.47

BCVA, best-corrected visual acuity; CFT, central foveal thickness; SRF, subretinal fluid; MD, mean deviation; SD, standard deviation.